These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22114930)

  • 41. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
    Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy").
    Colado MI; Granados R; O'Shea E; Esteban B; Green AR
    Pharmacol Toxicol; 1999 Jun; 84(6):261-6. PubMed ID: 10401727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
    Shih JH; Chiu CH; Ma KH; Huang YS; Shiue CY; Yeh TY; Kao LT; Lin YY; Li IH
    Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
    Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
    Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
    Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.
    Winsauer PJ; McCann UD; Yuan J; Delatte MS; Stevenson MW; Ricaurte GA; Moerschbaecher JM
    Psychopharmacology (Berl); 2002 Feb; 159(4):388-96. PubMed ID: 11823891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
    Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
    Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding.
    Piper BJ; Fraiman JB; Meyer JS
    Dev Psychobiol; 2005 Sep; 47(2):145-57. PubMed ID: 16136551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
    Rodsiri R; Green AR; Marsden CA; Fone KC
    J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.
    Rodsiri R; Spicer C; Green AR; Marsden CA; Fone KC
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):365-76. PubMed ID: 20645080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
    Baumann MH; Wang X; Rothman RB
    Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-induced neurodegeneration in rat brain.
    Colado MI; O'Shea E; Esteban B; Green AR
    Psychopharmacology (Berl); 2001 Aug; 157(1):82-8. PubMed ID: 11512047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity.
    O'Shea E; Sanchez V; Orio L; Escobedo I; Green AR; Colado MI
    Neuroscience; 2005; 135(4):1095-105. PubMed ID: 16165281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').
    O'Shea E; Granados R; Esteban B; Colado MI; Green AR
    Neuropharmacology; 1998 Jul; 37(7):919-26. PubMed ID: 9776387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity.
    Fone KC; Beckett SR; Topham IA; Swettenham J; Ball M; Maddocks L
    Psychopharmacology (Berl); 2002 Feb; 159(4):437-44. PubMed ID: 11823897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adolescent MDMA exposure diminishes the physiological and neurotoxic consequences of an MDMA binge in female rats.
    Piper BJ; Henderson CS; Meyer JS
    Dev Psychobiol; 2014 Jul; 56(5):924-34. PubMed ID: 24752593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.